Search Results - "Visnaw, Karen"

Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trial by Branch-Elliman, Westyn, Ferguson, Ryan, Doros, Gheorghe, Woods, Patricia, Leatherman, Sarah, Strymish, Judith, Datta, Rupak, Goswami, Rekha, Jankowich, Matthew D, Shah, Nishant R, Taylor, Thomas H, Page, Sarah T, Schiller, Sara J, Shannon, Colleen, Hau, Cynthia, Flynn, Maura, Holmberg, Erika, Visnaw, Karen, Dhond, Rupali, Brophy, Mary, Monach, Paul A

“…The aim of this pragmatic, embedded, adaptive trial was to measure the effectiveness of the subcutaneous anti-IL-6R antibody sarilumab, when added to an…”
Get full text

Implementation of documented and written informed consent for clinical trials of communicable diseases: Lessons learned, barriers, solutions, future directions identified during the conduct of a COVID-19 clinical trial by Woods, Patricia, Flynn, Maura, Monach, Paul, Visnaw, Karen, Schiller, Sara, Holmberg, Erika, Leatherman, Sarah, Ferguson, Ryan, Branch-Elliman, Westyn

“…The communicable nature of many infectious diseases, including SARS-CoV-2, creates challenges for implementing and obtaining regulatory-compliant written…”
Get full text

Patient- reported reasons for non-participation in a COVID-19 therapeutics clinical trial: Findings from a multi-center investigation by Dassum, Samira Reyes, Ferguson, Ryan, Woods, Patricia, Flynn, Maura, Visnaw, Karen, Holmberg, Erika, Schiller, Sara, Shannon, Colleen, Brophy, Mary, Monach, Paul, Leatherman, Sarah, Branch-Elliman, Westyn

“…Early in the pandemic, there were no evidence-based treatments for SARS-CoV-2, creating an urgent need to identify effective therapeutics. However, public…”
Get full text

Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2) by Al‐Naamani, Nadine, Krowka, Michael J., Forde, Kimberly A., Krok, Karen L., Feng, Rui, Heresi, Gustavo A., Dweik, Raed A., Bartolome, Sonja, Bull, Todd M., Roberts, Kari E., Austin, Eric D., Hemnes, Anna R., Patel, Mamta J., Oh, Jae K., Lin, Grace, Doyle, Margaret F., Denver, Nina, Andrew, Ruth, MacLean, Margaret R., Fallon, Michael B., Kawut, Steven M., Timmerman, Kasi, Mottram, C.D., Scanlon, Paul D., Miller, Adam, Visnaw, Karen, Homer, Natalie, Andrew, Ruth, Abbott, Cheryl, Palevsky, Harold I., Rajender Reddy, K., Goldberg, David S., Khungar, Vandana, Akaya Smith, K., Fritz, Jason S., Lynch, Marita, Sharkoski, Tiffany, Pinder, Diane, Machicao, Victor, Rubin, Moises Nevah, Walker, Kim, Cranford, Stacy, Varing, Jordan, Banga, Namrata, Igenoza, Oluwatosin, LaRochelle, Celeste

“…Background and Aims Portopulmonary hypertension (POPH) was previously associated with a single‐nucleotide polymorphism (SNP) rs7175922 in aromatase (cytochrome…”
Get full text

1065. Patient-Reported Reasons for Non-Participation in Inpatient COVID-19 Clinical Research: Results from a Multi-Center VA Embedded Randomized Trial by Reyes Dassum, Samira, Ferguson, Ryan, Woods, Patricia, Flynn, Maura, Visnaw, Karen, Schiller, Sara J, Monach, Paul, Leatherman, Sarah, Branch-Elliman, Westyn

“…Abstract Background Early in the COVID-19 pandemic, no evidence-proven therapeutics were approved, and thus participation in a clinical trial was often the…”
Get full text

517. Subcutaneous Sarilumab for the Treatment of Hospitalized patients with Moderate to Severe COVID19 Disease: A Pragmatic, Embedded, Multi-Center Randomized Clinical Trial by Branch-Elliman, Westyn, Ferguson, Ryan, Doros, Gheorghe, Woods, Patricia, Leatherman, Sarah, Strymish, Judith, Datta, Rupak, Goswami, Rekha, Jankowich, Matthew, Shah, Nishant, Taylor, Thomas H, Page, Sarah T, Schiller, Sara, Shannon, Colleen, Hau, Cynthia, Flynn, Maura, Holmberg, Erika, Visnaw, Karen, Dhond, Rupali, Brophy, Mary, Monach, Paul

“…Abstract Background The aim of this pragmatic, embedded adaptive trial was to measure the effectiveness of subcutaneous sarilumab in addition to an evolving…”
Get full text

Letter from the editor by Visnaw, Karen

Get full text

Letter from the editor by Visnaw, Karen

Get full text

Letter from the editor by Visnaw, Karen

Get full text

Letter from the editor by Visnaw, Karen

Get full text

Letter from the editor by Visnaw, Karen

Get full text

Letter from the editor by Visnaw, Karen

Get full text

Letter from the editor by Visnaw, Karen

Get full text

Letter from the editor by Visnaw, Karen

Get full text